ArticleScientific reports2022

Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation.

Wei-Ru Chiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.